| Pulmonary absorption–estimation of effective pulmonary permeability and tissue retention of ten drugs using an ex vivo rat model and computational analysis J Eriksson, E Sjögren, H Thörn, K Rubin, P Bäckman, H Lennernäs European Journal of Pharmaceutics and Biopharmaceutics 124, 1-12, 2018 | 40 | 2018 |
| Excised segments of rat small intestine in Ussing chamber studies: A comparison of native and stripped tissue viability and permeability to drugs E Sjögren, J Eriksson, C Vedin, K Breitholtz, C Hilgendorf International Journal of Pharmaceutics 505 (1-2), 361-368, 2016 | 33 | 2016 |
| Pulmonary dissolution of poorly soluble compounds studied in an ex vivo rat lung model J Eriksson, H Thörn, E Sjögren, L Holmstén, K Rubin, H Lennernäs Molecular Pharmaceutics 16 (7), 3053-3064, 2019 | 26 | 2019 |
| Pesticide-induced multigenerational effects on amphibian reproduction and metabolism O Karlsson, S Svanholm, A Eriksson, J Chidiac, J Eriksson, F Jernerén, ... Science of the Total Environment 775, 145771, 2021 | 24 | 2021 |
| Drug Absorption Parameters Obtained Using the Isolated Perfused Rat Lung Model Are Predictive of Rat In Vivo Lung Absorption J Eriksson, E Sjögren, H Lennernäs, H Thörn The AAPS Journal 22, 1-12, 2020 | 18 | 2020 |
| Pulmonary drug absorption and systemic exposure in human: predictions using physiologically based biopharmaceutics modeling J Eriksson, H Thörn, H Lennernäs, E Sjögren European Journal of Pharmaceutics and Biopharmaceutics 156, 191-202, 2020 | 16 | 2020 |
| Steel and its heat treatment L Andersson, K Berggren, J Bodin, MT Ferrari, A Eriksson, J Eriksson, ... Swerea IVF, Mölndal, Gothenburg, 2012 | 5 | 2012 |
| Drug Absorption Parameters Obtained Using the Isolated Perfused Rat Lung Model Are Predictive of Rat In Vivo Lung Absorption (vol 22, 71, 2020) J Eriksson, E Sjogren, H Lennernas, H Thorn AAPS JOURNAL 23 (1), 2021 | 1 | 2021 |
| Bioavailability of three novel oral, sustained‐release pellets, relative to an immediate‐release tablet containing 500 mg flucytosine: A randomized, open‐label, crossover study … V Goyal, E Krantz, F Simon, A Neven, J Eriksson, A Saayman, ... Clinical and Translational Science 17 (3), e13756, 2024 | | 2024 |
| PA-298 Predicting disease effect on the pharmacokinetics (PK) of sustained and immediate release formulations by applying physiologically based pharmacokinetic (PBPK) modelling J Eriksson, E Sjögren, JY Gillon, V Goyal, V Satam, S Robinson, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
| Physiologically based pharmacokinetic modelling of rilpivirine and lenacapavir delivery by microarray patches for treatment of pediatric HIV infection RKM Choy, J Mistilis, L Vora, FV Zanutto, AHB Sabri, I Tekko, K Moffatt, ... 7th International Conference on Microneedles 2023, 2023 | | 2023 |
| Drug absorption in the lungs: studies in the isolated perfused rat lung model combined with physiologically based biopharmaceutics modelling J Eriksson Acta Universitatis Upsaliensis, 2021 | | 2021 |
| Correction to: Drug Absorption Parameters Obtained Using the Isolated Perfused Rat Lung Model Are Predictive of Rat In Vivo Lung Absorption J Eriksson, E Sjögren, H Lennernäs, H Thörn The AAPS Journal 23 (1), 2021 | | 2021 |
| Investigation of pulmonary drug permeability and tissue retention by computational analysis of rat ex vivo lung absorption profiles J Eriksson, E Sjogren, H Thorn, K Rubin, P Backman, H Lennernas JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 31 (2), A8-A9, 2018 | | 2018 |
| Predicting disease effect on the pharmacokinetics (PK) of sustained and immediate release formulations of flucytosine by applying physiologically based pharmacokinetic (PBPK … J Eriksson, E Sjögren, JY Gillon, V Goyal, S Robinson, H Caplain, ... | | |
| Physiologically-Based Pharmacokinetic (PBPK) Modeling of Oral Absorption of 5-flucytosine to Support Development of a Sustained-Release Formulation for Treatment of … J Eriksson, E Sjögren, JY Gillon, V Goyal, V Satam, S Robinson | | |
| Physiologically based pharmacokinetic (PBPK) modelling of cabotegravir (CAB) to support design of microarray patches (MAPs) for the treatment of HIV positive children J Eriksson, E Sjögren, M Pellowe, RKM Choy, J Mistilis, C Jarrahian, ... | | |
| The Serosal Layer’s Potential Impact On Rat Intestinal Tissue Viability And Permeability E Sjögren, C Roos, J Eriksson, C Vedin, K Breitholtz, C Hilgendorf | | |
